Skip to main content
. 2019 Nov 25;57(5):888–895. doi: 10.1093/ejcts/ezz320

Table 2:

Comparison of patients with all stages undergoing lobectomy by RATS, VATS and OPEN

Variables Groups RATS VATS OPEN P-value
Overall count, N (%) 5470 (8.5) 17 545 (27.1) 41 661 (64.4)
Age (years), mean (SD) 66.8 (9.8) 66.6 (10.2) 66.3 (10.3) 0.001
Gender Male (%) 2421 (44.3) 7696 (43.9) 19 895 (47.8) <0.01
Race, N (%) White 4700 (85.9) 15 235 (86.8) 36 216 (86.9) <0.01
Black 532 (9.7) 1446 (8.2) 3833 (9.2)
Other 238 (4.4) 864 (4.9) 1612 (3.9)
Histology, N (%) Squamous 1214 (22.2) 3877 (22.1) 10 998 (26.4) <0.01
Adeno 3880 (70.9) 12 372 (70.5) 27 163 (65.2)
Others 376 (6.9) 1296 (7.4) 3500 (8.4)
Stage, N (%) I 4389 (80.4) 13 678 (78.2) 29 623 (71.3) <0.01
II 730 (13.4) 2599 (14.9) 7998 (19.2)
III 267 (4.9) 945 (5.4) 3137 (7.5)
IV 70 (1.3) 265 (1.5) 813 (2.0)
Grade, N (%) I/II 3443 (62.9) 10 747 (61.3) 24 685 (59.3) <0.01
III/IV 1677 (30.7) 5569 (31.7) 14 435 (34.6)
Unknown 350 (6.4) 1229 (7.0) 2541 (6.1)
Conversion, N (%) 515 (9.4) 2878 (16.4) <0.01
CDS, N (%) 0 2674 (48.9) 9035 (51.5) 21 045 (50.5) <0.01
1 2018 (36.9) 6153 (35.1) 14 635 (35.1)
2 778 (14.2) 2357 (13.4) 5981 (14.4)
LNE, mean (SD) 10.9 (7.9) 11.3 (8.9) 10 (7.5) <0.01
N stage, N (%) Upstaged 595 (11.2) 1967 (11.7) 4960 (12.6) <0.01
Downstaged 156 (2.9) 588 (3.5) 1631 (4.1)
Same 4550 (85.8) 14 220 (79.4) 32 869 (83.3)
30/90-Day mortality (%) 1.8/3.2 1.8/3.1 2.4/4.6 <0.01
LOS, median (days) 4 5 6 <0.01
5-Year survival (HR) 0.65 (0.61–0.68) 0.66 (0.65–0.67) 0.60 (0.60–0.61) <0.01

CDS: Charlson–Deyo Score; HR: hazard ratio; LNE: lymph nodes examined; LOS: length of stay; OPEN: open thoracotomy; RATS: robot-assisted thoracic surgery; SD: standard deviation; VATS: video-assisted thoracic surgery.